Skip to main content

Want a detailed portfolio tracker?

ATAI Life Sciences N.V. (ATAI) P/E (2025 - 2026)

ATAI Life Sciences N.V. (ATAI) P/E from Mar 31, 2025 to Jul 21, 2026. The TTM ATAI Life Sciences N.V. (ATAI) P/E is -87.59. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of ATAI Life Sciences N.V. (ATAI)

YearP/EChange
2026-87.59+236.98%
2025-25.99N/A

Comparison ATAI Life Sciences N.V. (ATAI) P/E with competitors

ATAI Life Sciences N.V. (ATAI) P/E is -87.59.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.00-100.00%
ENLVEnlivex Ltd0.07-100.09%
FGENFibroGen Inc0.24-100.27%
CHRSCoherus Biosciences Inc0.85-100.97%
FBIOFortress Biotech Inc0.95-101.08%
ORMPOramed Pharmaceuticals Inc1.50-101.72%
AGENAgenus Inc3.01-103.44%
INVAInnoviva Inc3.15-103.60%
VXRTVaxart Inc3.55-104.05%
CRMDCorMedix Inc3.63-104.14%
CVACCureVac N.V.4.45-105.08%
GLPGGalapagos NV4.86-105.55%
SRPTSarepta Therapeutics Inc4.88-105.57%
ABEOAbeona Therapeutics Inc5.39-106.15%
ABUSArbutus Biopharma Corp5.60-106.39%
ZVRAZevra Therapeutics Inc5.89-106.72%
SPROSpero Therapeutics Inc6.23-107.11%
CGENCompugen Ltd6.31-107.21%
RIGLRigel Pharmaceuticals6.87-107.85%
SLXNSilexion Therapeutics Corp7.30-108.33%
OMEROmeros Corporation9.26-110.57%
AUPHAurinia Pharmaceuticals Inc9.58-110.94%
PLXProtalix BioTherapeutics Inc10.89-112.43%
ACADAcadia Pharmaceuticals Inc11.73-113.39%
TBPHTheravance Biopharma Inc12.26-114.00%
ADMAAdma Biologics Inc12.42-114.18%
HRMYHarmony Biosciences Holdings Inc13.82-115.78%
SABSSAB Biotherapeutics Inc14.14-116.14%
NAGENiagen Bioscience Inc14.82-116.92%
INCYIncyte Corp15.82-118.06%
REGNRegeneron Pharmaceuticals Inc15.86-118.10%
PBYIPuma Biotechnology Inc17.32-119.77%
CPRXCatalyst Pharmaceuticals Inc17.44-119.91%
EXELExelixis Inc17.54-120.02%
TGTXTG Therapeutics Inc18.97-121.65%
MDXGMimedx Group Inc20.55-123.46%
XOMAXOMA Royalty Corp22.87-126.12%
ARGXArgen X SE24.30-127.74%
CTMXCytomX Therapeutics Inc24.82-128.34%
XOMAOXOMA Royalty Corp25.34-128.94%
HALOHalozyme Therapeutics Inc25.62-129.26%
XOMAPXOMA Royalty Corp25.67-129.31%
VRTXVertex Pharmaceuticals Inc27.99-131.96%
RPRXRoyalty Pharma plc - Class A28.69-132.75%
SLNOSoleno Therapeutics Inc29.02-133.13%
LGNDLigand Pharmaceuticals Inc - Class B37.91-143.29%
APLSApellis Pharmaceuticals Inc39.02-144.55%
BMRNBiomarin Pharmaceutical Inc42.21-148.19%
KRYSKrystal Biotech Inc45.34-151.77%
ONCBeiGene Ltd69.54-179.40%
PHARPharming Group N.V.75.03-185.66%
TECHBio-Techne Corp101.96-216.41%
VCELVericel Corp109.92-225.50%
ALNYAlnylam Pharmaceuticals Inc117.96-234.68%
GMABGenmab140.29-260.17%
TLXTelix Pharmaceuticals Ltd162.15-285.14%
CORTCorcept Therapeutics Inc212.86-343.03%